Search

Objective: Epilepsy is a common neurological disorder, the history of which dates back to thousands of years ago. Avicenna (980-1037 AD) is a famous Persian scholar who considered different types of epilepsy and their specific treatments. His book Al-Qanun fi al-Tibb was taught in Europe for several years. Along with explaining the diseases occurring in various body organs, the book describes neurological and neuropsychological conditions such as epilepsy METHODS: This article is a review of the book Al-Qanun fi al-Tibb and some of the traditional Persian medicine sources, including Kāmil al-Sināa al Tibbiya and Makhzan-O-L Advieh, on uterine epilepsy, its etiology, clinical manifestations and treatments. Also, articles related to this topic in the field of traditional Persian medicine or historical articles have been searched for in Google Scholar search engine or PubMed database.Results: Avicenna categorizes the causes of epilepsy into two main groups: those caused by brain diseases and those associated with the diseases of other organs. He believed that the stomach, the spleen, the maraqq, the uterus, or other body organs influence the brain and can cause epilepsy. In uterine epilepsy, the primary pathology lies with the uterus and can affect the brain. This condition occurs due to the retention of the menses or semen.Conclusion: In this historical article, we intend to explain Avicenna's viewpoint on uterine epilepsy. We suggest further studies on this topic, for example, to evaluate the frequency of epilepsy in patients with the retention of the menses or the semen. [ABSTRACT FROM AUTHOR]

Scenario techniques are to be used in the field of energy for development of planning and as well as management. Large numbers of studies and researches have been reported by the Shell, IEA (International Energy Agency), WEC (World Energy Council), etc. based on the scenario techniques for visualizing of energy status. This study presents a Scenario-Based Model based on assumption about Iran׳s energy future. For this purpose, a conceptual framework and implementation of the method were presented. Afterwards, four scenarios were generated namely: Orange cake, Green horizon, Critical point, Wishful thinking. Scenarios in three-dimensional (political, science and technology (S&T) and environmental) aspects of energy were presented. Results showed that the green horizon scenario has a high convergence for long-term occurrence probability. The three-dimensional distance among the scenarios in the mentioned dimensions indicates that the main variables that shape the future of Iran׳s energy would act in coordination regardless of the category they are placed in. [ABSTRACT FROM AUTHOR]

Abstract: Iran as a major oil producing country has increasingly paid attention to the non-fossil energy resources, in particular to renewable energy sources for its longer term energy plans. In this regard, 11 projects pertaining to solar energy are being utilized or carried out by Iran׳s Ministry of Energy. The total photovoltaic power installed in 2004 was 14,020MW. This rate reached 67MW by the end of 2010. Further, two geothermal projects are being constructed in Ardabil Province at present. By the end of 2010, the Meshkinshahr geothermal power plant project revealed a progress rate equal to 50%. Similarly, the package construction project in Ardabil revealed a 32% progress. Due to financial hardship in the Fourth Development Program, the completion of these projects was extended to the end of the Fifth Development Program. The nameplate power of biogas power plants in Iran is 1.860MW the total installed capacity is 1.665MW. According to Strategy Document of Fuel Cell Technology Development (Approved by the government in 2004), Iran has revealed good progress in fuel cell projects. Private sectors have already signed contracts to build more than 600MW of biomass systems and 500MW of new wind energy developments. The nominal power of the wind parks that can be erected in the available sites with remarkable wind potential in Iran is approximately 6500MW, employing wind turbines of 60,000MW nominal power. The estimated mean annual capacity factor of these wind parks is 33%. [Copyright &y& Elsevier]

Objective: The effect of lavender syrup on COVID-19-induced olfactory dysfunction (OD) has been assessed in this study. Materials and Methods: This pilot clinical trial was conducted in Gonbad-E-Kavoos (Golestan province, Iran). Twenty-three outpatients with COVID-19 and OD in lavender group took 9 ml of lavender syrup/bid for 3 weeks along with the standard COVID-19 treatments and 20 patients in control group took only standard COVID-19 treatments. The severity of OD was assessed by the visual analogue scale (VAS). Data analysis was performed by Friedman and Mann-Whitney tests using SPSS software. Results: The mean± standard deviation of age was 36.6±9.1, and 42.6±10.4 years (p=0.05), and the duration of symptoms was 7.4±3.5, and 7.5±3.4 days (p=0.98) in the lavender and control group, respectively. The VAS score for OD decreased from 6.8±3.04 to 0.26±0.86 in the lavender group and from 5.3±3.4 to 1±2.61 in the control group. Although, VAS for OD was significantly decreased in both groups (p<0.001), the amount of VAS decrease was 6.6±2.9 scores in the lavender group, and 4.3±4 in the control group (p=0.03). No side effects were observed in the lavender group. Conclusion: The present study showed that lavender syrup is an effective treatment for COVID-19-induced OD. It is suggested to conduct further studies with larger sample size. [ABSTRACT FROM AUTHOR]

Background: Data on the epidemiology of inflammatory bowel disease (IBD) in the Middle East are scarce. We aimed to describe the clinical phenotype, disease course, and medication usage of IBD cases from Iran in the Middle East. Methods: We conducted a cross-sectional study of registered IBD patients in the Iranian Registry of Crohn's and Colitis (IRCC) from 2017 until 2022. We collected information on demographic characteristics, past medical history, family history, disease extent and location, extra-intestinal manifestations, IBD medications, and activity using the IBD-control-8 questionnaire and the Manitoba IBD index, admissions history, history of colon cancer, and IBD-related surgeries. Results: In total, 9746 patients with ulcerative colitis (UC) (n = 7793), and Crohn's disease (CD) (n = 1953) were reported. The UC to CD ratio was 3.99. The median age at diagnosis was 29.2 (IQR: 22.6,37.6) and 27.6 (IQR: 20.6,37.6) for patients with UC and CD, respectively. The male-to-female ratio was 1.28 in CD patients. A positive family history was observed in 17.9% of UC patients. The majority of UC patients had pancolitis (47%). Ileocolonic involvement was the most common type of involvement in CD patients (43.7%), and the prevalence of structuring behavior was 4.6%. A prevalence of 0.3% was observed for colorectal cancer among patients with UC. Moreover,15.2% of UC patients and 38.4% of CD patients had been treated with anti-tumor necrosis factor (anti-TNF). Conclusion: In this national registry-based study, there are significant differences in some clinical phenotypes such as the prevalence of extra-intestinal manifestations and treatment strategies such as biological use in different geographical locations. [ABSTRACT FROM AUTHOR]

Reviewing ancient manuscripts of Persian medicine (PM) reveals that there have been some basic principles for decision-making in epidemic infectious diseases that existed in the past. These PM rules for clinical reasoning were applied through a personalized approach along with public health advice in such situations. Currently, the coronavirus pandemic has been the biggest problem in the world. Its mainstay of treatment is based on preventative measures and symptomatic treatments. Meanwhile, traditional medical systems for providing preventive, supportive, and rehabilitative care to patients have received more attention than before. Thus, the specific individual approach considered by PM scholars for clinical courses of epidemic infectious diseases may help shed more light on the spread of knowledge on epidemic diseases in ancient Persia. [ABSTRACT FROM AUTHOR]